International Clinical Trial: A Study to Learn About How the Body Processes the Study Medicine Called PF-07328948 in Healthy Chinese Adults

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07455240) titled 'A Study to Learn About How the Body Processes the Study Medicine Called PF-07328948 in Healthy Chinese Adults' on March 3.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).

Primary Sponsor: Pfizer

Condition: Healthy Participant

Intervention: Drug: PF-07328948

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: March 15, 2026

Target Sample Size: 10

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07455240

Disclaimer: Curated by HT Synd...